Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Biotech Rebounds on Optimism and Deal Making

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Aug 19, 2022 12:25pm

339 Views

Post# 34907646

Biotech Rebounds on Optimism and Deal Making

Lets see if we can benefit from this momentum, on news.

Biotech Rebounds on Optimism and Deal Making

Sector had tumbled in selloff but gets boost from big investors and pharmaceutical companies

Biotech stocks, some of the biggest losers in the selloff, are soaring.

The speculative sector is getting a boost from renewed optimism among investors. Fundamental drivers such as deal making, new drug approvals and buying by big investors provide confidence that the rally could persist.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record